antibody anti ki67  (Boster Bio)


Bioz Verified Symbol Boster Bio is a verified supplier
Bioz Manufacturer Symbol Boster Bio manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Boster Bio antibody anti ki67
    E2F1 knockout inhibits PTC tumor growth in vivo . (a) Tumor volume assessment. (b) Images of transplanted tumors in nude mice. (c) Weights of transplanted tumor in nude mice. (d) Expression patterns of LINC00152 and E2F1 mRNA detected by RT-qPCR. (e) Level of E2F1 protein verified through Western blot analysis. (f) <t>Ki67</t> <t>positive</t> expression patterns measured by immunohistochemical staining. N = 6. Data are expressed as mean ± standard deviation. The t -test was used for pairwise comparison. ∗∗ p
    Antibody Anti Ki67, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody anti ki67/product/Boster Bio
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    antibody anti ki67 - by Bioz Stars, 2022-07
    94/100 stars

    Images

    1) Product Images from "Transcription Factor E2F1 Exacerbates Papillary Thyroid Carcinoma Cell Growth and Invasion via Upregulation of LINC00152"

    Article Title: Transcription Factor E2F1 Exacerbates Papillary Thyroid Carcinoma Cell Growth and Invasion via Upregulation of LINC00152

    Journal: Analytical Cellular Pathology (Amsterdam)

    doi: 10.1155/2022/7081611

    E2F1 knockout inhibits PTC tumor growth in vivo . (a) Tumor volume assessment. (b) Images of transplanted tumors in nude mice. (c) Weights of transplanted tumor in nude mice. (d) Expression patterns of LINC00152 and E2F1 mRNA detected by RT-qPCR. (e) Level of E2F1 protein verified through Western blot analysis. (f) Ki67 positive expression patterns measured by immunohistochemical staining. N = 6. Data are expressed as mean ± standard deviation. The t -test was used for pairwise comparison. ∗∗ p
    Figure Legend Snippet: E2F1 knockout inhibits PTC tumor growth in vivo . (a) Tumor volume assessment. (b) Images of transplanted tumors in nude mice. (c) Weights of transplanted tumor in nude mice. (d) Expression patterns of LINC00152 and E2F1 mRNA detected by RT-qPCR. (e) Level of E2F1 protein verified through Western blot analysis. (f) Ki67 positive expression patterns measured by immunohistochemical staining. N = 6. Data are expressed as mean ± standard deviation. The t -test was used for pairwise comparison. ∗∗ p

    Techniques Used: Knock-Out, In Vivo, Mouse Assay, Expressing, Quantitative RT-PCR, Western Blot, Immunohistochemistry, Staining, Standard Deviation

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94
    Boster Bio ki67 antibodies
    Supplementation with pasteurised A. muciniphila or Amuc_1100 blunted tumourigenesis induced by azoxymethane (AOM)/DSS. (A) Weight changes are expressed as the mean change from the starting weight. (B) DAI, (C) spleen weight, (D) tumour development, number (E) and tumour area (F) were analysed. (G) Representative histological images of colon tissues by H E staining. Scale bars, 200 µm. IHC staining and quantitation of γH2AX (8 weeks, H), cleaved-caspase 3 (23 weeks, I) and <t>Ki67</t> (23 weeks, J) in the proximal colon. Scale bars, 50 µm. Data are presented as the mean±SEM and were analysed by ordinary one-way ANOVA with Tukey’s multiple comparisons. *P
    Ki67 Antibodies, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ki67 antibodies/product/Boster Bio
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ki67 antibodies - by Bioz Stars, 2022-07
    94/100 stars
      Buy from Supplier

    92
    Boster Bio antibodies against ki 67
    Effects of upregulation and downregulation of MALAT1 on U87 and U251 cell proliferation. ( a and b ) Cellular proliferation of untransfected or transfected U87 and U251 cells was measured using a CCK-8 assay daily for 3 days. ( c ) Cellular proliferation of untransfected or transfected U87 and U251 cells was measured by testing the expression of <t>Ki-67.</t> ( d and e ) The percentage of Ki-67-positive cells was calculated. Results are expressed as mean±S.D. from three independent experiments ( P
    Antibodies Against Ki 67, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against ki 67/product/Boster Bio
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    antibodies against ki 67 - by Bioz Stars, 2022-07
    92/100 stars
      Buy from Supplier

    Image Search Results


    Supplementation with pasteurised A. muciniphila or Amuc_1100 blunted tumourigenesis induced by azoxymethane (AOM)/DSS. (A) Weight changes are expressed as the mean change from the starting weight. (B) DAI, (C) spleen weight, (D) tumour development, number (E) and tumour area (F) were analysed. (G) Representative histological images of colon tissues by H E staining. Scale bars, 200 µm. IHC staining and quantitation of γH2AX (8 weeks, H), cleaved-caspase 3 (23 weeks, I) and Ki67 (23 weeks, J) in the proximal colon. Scale bars, 50 µm. Data are presented as the mean±SEM and were analysed by ordinary one-way ANOVA with Tukey’s multiple comparisons. *P

    Journal: Gut

    Article Title: A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice

    doi: 10.1136/gutjnl-2019-320105

    Figure Lengend Snippet: Supplementation with pasteurised A. muciniphila or Amuc_1100 blunted tumourigenesis induced by azoxymethane (AOM)/DSS. (A) Weight changes are expressed as the mean change from the starting weight. (B) DAI, (C) spleen weight, (D) tumour development, number (E) and tumour area (F) were analysed. (G) Representative histological images of colon tissues by H E staining. Scale bars, 200 µm. IHC staining and quantitation of γH2AX (8 weeks, H), cleaved-caspase 3 (23 weeks, I) and Ki67 (23 weeks, J) in the proximal colon. Scale bars, 50 µm. Data are presented as the mean±SEM and were analysed by ordinary one-way ANOVA with Tukey’s multiple comparisons. *P

    Article Snippet: The sections were then blocked and stained with CD8a, F4/80, cleaved-caspase 3, γH2AX or Ki67 antibodies, followed by corresponding secondary antibody and a Streptavidin Biotin Complex kit (Boster BioEngineering, Wuhan, China).

    Techniques: Staining, Immunohistochemistry, Quantitation Assay

    Histological changes of AB-PAS + goblet cells and proliferative cells (Ki67 + ) in MK2 lyz2−WT and MK2 lyz2−KO mice after 7 days' treatment of 3.5% DSS or water control. (A) Representative images showing AB-PAS + goblet cells in colon sections from MK2 lyz2−WT and MK2 lyz2−KO mice. Scale bars: 100 μm (upper), 40 μm (lower). (B) Statistical analysis of AB-PAS + goblet cells in each crypt. (C) Representative images showing proliferative cells (Ki67 + ) in colon of DSS treatment mice. Scale bars, 100 μm (upper), 40 μm (lower). (D) Statistical analysis of Ki67 + cells in each crypt. The results were shown as means ± SEM. * P

    Journal: Frontiers in Medicine

    Article Title: MK2 Is Required for Neutrophil-Derived ROS Production and Inflammatory Bowel Disease

    doi: 10.3389/fmed.2020.00207

    Figure Lengend Snippet: Histological changes of AB-PAS + goblet cells and proliferative cells (Ki67 + ) in MK2 lyz2−WT and MK2 lyz2−KO mice after 7 days' treatment of 3.5% DSS or water control. (A) Representative images showing AB-PAS + goblet cells in colon sections from MK2 lyz2−WT and MK2 lyz2−KO mice. Scale bars: 100 μm (upper), 40 μm (lower). (B) Statistical analysis of AB-PAS + goblet cells in each crypt. (C) Representative images showing proliferative cells (Ki67 + ) in colon of DSS treatment mice. Scale bars, 100 μm (upper), 40 μm (lower). (D) Statistical analysis of Ki67 + cells in each crypt. The results were shown as means ± SEM. * P

    Article Snippet: Then, sections were incubated with anti-Ki67 antibody overnight at 4°C, followed by incubation with horseradish peroxidase (HRP) secondary antibodies for 20 min.

    Techniques: Mouse Assay

    COX2/PGE 2 mediates the proliferation promoting function of IL-33. a , b The relative mRNA levels of Ki67 ( a ) and PCNA ( b ) in primary CRC cells responding to rhIL-33 (100 ng/mL) incubation and/ or indicated inhibitors (SB203580, 10 μg/mL; PD98059, 20 μg/mL; SP600125, 10 μg/mL; BIX01294, 2 μM; 5Aza, 10 μM; SC560, 0.1 μg/mL; celecoxib, 20 μg/mL) for 24 h. c The relative mRNA levels of Ki67 and PCNA in HT-29 cells incubated with rhIL-33 (100 ng/mL) or/ and celecoxib (CXB) (20 μg/mL) in medium for 24 h. d The relative mRNA levels of Ki67 and PCNA in MC38 cells incubated with rmIL-33 (100 ng/mL) or/ and celecoxib (CXB) (20 μg/mL) in medium for 24 h. e , f The mRNA ( e ) and protein ( f ) expression of COX2 in primary CRC cells incubated with 0, 50 or 100 ng/mL of rhIL-33 in medium for 24 h. g PGE 2 concentrations in the supernatants of primary CRC cells incubated with rhIL-33-contained RPMI medium or blank RPMI medium for 48 h. h Cell viabilities of primary CRC cells incubated with or without PGE 2 (50 ng/mL) in medium. i The flat colony formation of primary CRC cells incubated for 15 days in medium containing different factors as indicated (IL-33, 100 ng/mL; celecoxib, 20 μg/mL; anti-PGE 2 , 2 μg/mL). The representative images of colonies and the statistical data are shown. Three parallel wells were set for each treatment. Each experiment was performed three times. Data expressed as mean ± SEM. * P

    Journal: Journal of Experimental & Clinical Cancer Research : CR

    Article Title: IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE2

    doi: 10.1186/s13046-018-0839-7

    Figure Lengend Snippet: COX2/PGE 2 mediates the proliferation promoting function of IL-33. a , b The relative mRNA levels of Ki67 ( a ) and PCNA ( b ) in primary CRC cells responding to rhIL-33 (100 ng/mL) incubation and/ or indicated inhibitors (SB203580, 10 μg/mL; PD98059, 20 μg/mL; SP600125, 10 μg/mL; BIX01294, 2 μM; 5Aza, 10 μM; SC560, 0.1 μg/mL; celecoxib, 20 μg/mL) for 24 h. c The relative mRNA levels of Ki67 and PCNA in HT-29 cells incubated with rhIL-33 (100 ng/mL) or/ and celecoxib (CXB) (20 μg/mL) in medium for 24 h. d The relative mRNA levels of Ki67 and PCNA in MC38 cells incubated with rmIL-33 (100 ng/mL) or/ and celecoxib (CXB) (20 μg/mL) in medium for 24 h. e , f The mRNA ( e ) and protein ( f ) expression of COX2 in primary CRC cells incubated with 0, 50 or 100 ng/mL of rhIL-33 in medium for 24 h. g PGE 2 concentrations in the supernatants of primary CRC cells incubated with rhIL-33-contained RPMI medium or blank RPMI medium for 48 h. h Cell viabilities of primary CRC cells incubated with or without PGE 2 (50 ng/mL) in medium. i The flat colony formation of primary CRC cells incubated for 15 days in medium containing different factors as indicated (IL-33, 100 ng/mL; celecoxib, 20 μg/mL; anti-PGE 2 , 2 μg/mL). The representative images of colonies and the statistical data are shown. Three parallel wells were set for each treatment. Each experiment was performed three times. Data expressed as mean ± SEM. * P

    Article Snippet: The sections were labeled with anti-Ki67 antibody (Arigo, 1:200) and anti-PCNA antibody (Boster, 1:200).

    Techniques: Incubation, Expressing

    IL-33 promotes CRC proliferation both in vivo and in vitro. a Correlation between IL-33 transcripts and the genes involved in the regulation of cell proliferation in CRC. Gene set enrichment analysis was performed using CRC TCGA database. NES = 1.03, P = 0.03. b Growth curves of MC38 tumors inoculated in IL-33 transgenic mice (IL-33 TG) or wild-type mice (WT). n = 7. c , d Immunohistochemical staining of Ki67 ( c ) and PCNA ( d ) in the MC38 tumors recovered from wild-type and IL-33 transgenic mice at Day 22 post inoculation. The representative images and the statistical proportions of positive cells are shown. Scale bar, 50 μm. n = 7. Data expressed as mean ± SEM. **, P

    Journal: Journal of Experimental & Clinical Cancer Research : CR

    Article Title: IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE2

    doi: 10.1186/s13046-018-0839-7

    Figure Lengend Snippet: IL-33 promotes CRC proliferation both in vivo and in vitro. a Correlation between IL-33 transcripts and the genes involved in the regulation of cell proliferation in CRC. Gene set enrichment analysis was performed using CRC TCGA database. NES = 1.03, P = 0.03. b Growth curves of MC38 tumors inoculated in IL-33 transgenic mice (IL-33 TG) or wild-type mice (WT). n = 7. c , d Immunohistochemical staining of Ki67 ( c ) and PCNA ( d ) in the MC38 tumors recovered from wild-type and IL-33 transgenic mice at Day 22 post inoculation. The representative images and the statistical proportions of positive cells are shown. Scale bar, 50 μm. n = 7. Data expressed as mean ± SEM. **, P

    Article Snippet: The sections were labeled with anti-Ki67 antibody (Arigo, 1:200) and anti-PCNA antibody (Boster, 1:200).

    Techniques: In Vivo, In Vitro, Transgenic Assay, Mouse Assay, Immunohistochemistry, Staining

    Effects of upregulation and downregulation of MALAT1 on U87 and U251 cell proliferation. ( a and b ) Cellular proliferation of untransfected or transfected U87 and U251 cells was measured using a CCK-8 assay daily for 3 days. ( c ) Cellular proliferation of untransfected or transfected U87 and U251 cells was measured by testing the expression of Ki-67. ( d and e ) The percentage of Ki-67-positive cells was calculated. Results are expressed as mean±S.D. from three independent experiments ( P

    Journal: Cell Death & Disease

    Article Title: Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling

    doi: 10.1038/cddis.2015.407

    Figure Lengend Snippet: Effects of upregulation and downregulation of MALAT1 on U87 and U251 cell proliferation. ( a and b ) Cellular proliferation of untransfected or transfected U87 and U251 cells was measured using a CCK-8 assay daily for 3 days. ( c ) Cellular proliferation of untransfected or transfected U87 and U251 cells was measured by testing the expression of Ki-67. ( d and e ) The percentage of Ki-67-positive cells was calculated. Results are expressed as mean±S.D. from three independent experiments ( P

    Article Snippet: Slides were incubated with primary antibodies against Ki-67 (Boster Bioengineering Co., Wuhan, China), and with antibodies against MMP2 and TIMP3 (Abcam).

    Techniques: Transfection, CCK-8 Assay, Expressing